Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias.

Saved in:
Bibliographic Details
Title: Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias.
Authors: Raundhal M; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA. Mahesh_Raundhal@dfci.harvard.edu.; Department of Immunology, Harvard Medical School, Boston, MA, USA. Mahesh_Raundhal@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. Mahesh_Raundhal@dfci.harvard.edu., Ghosh S; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Myers SA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Cuoco MS; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA., Singer M; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Carr SA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Waikar SS; Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Renal Section, Boston University Medical Center, Boston, MA, USA., Bonventre JV; Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Steensma DP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Regev A; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA.; Koch Institute for Integrative Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA., Glimcher LH; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA. Laurie_Glimcher@dfci.harvard.edu.; Department of Immunology, Harvard Medical School, Boston, MA, USA. Laurie_Glimcher@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. Laurie_Glimcher@dfci.harvard.edu.
Source: Nature immunology [Nat Immunol] 2021 Nov; Vol. 22 (11), pp. 1465.
Publication Type: Published Erratum
Journal Info: Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1529-2916
DOI:10.1038/s41590-021-01031-y